A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT05806996
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Bladder Spasms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Magnesium — DRUG
    Intravenous infusion, load 50 mg/Kg with infusion of 15 mg/Kg/hour
  • Placebo — DRUG
    Equivalent volume of normal saline

Study Details

This research is being done to find out whether intravenous magnesium is effective in the treatment of bladder spasms after urologic surgery.

Key Dates

Start date
Jul 31, 2023
Status verified
May 2025
Primary completion
Jun 30, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
120 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Magnesium Group
    Subjects having urology surgery per standard of care will receive intravenous magnesium during the surgery.
  • Placebo Comparator: Placebo Group
    Subjects having urology surgery per standard of care will receive intravenous placebo during the surgery.

Primary Outcome Measure

Incidence of bladder spasm [ Time Frame: Post-operative, approximately 1 hour ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in MinnesotaRochesterMinnesota55905
Holly Carlson

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Minnesota· Rochester, MN